How many drugs treat Biliary tract cancer?

Drug Landscape tracks 2 marketed treatments for Biliary tract cancer (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/biliary-tract-cancer.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Biliary tract cancer — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biliary tract cancer (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Biliary tract cancer, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Pemazyre	PEMIGATINIB	Incyte Corp	Kinase Inhibitor [EPC]	Fibroblast growth factor receptor 1		2020-01-01
Tibsovo	IVOSIDENIB	Servier	Isocitrate Dehydrogenase 1 Inhibitor [EPC]	mutant IDH1		2018-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Incyte Corp · 1 drug in Biliary tract cancer
Servier · 1 drug in Biliary tract cancer

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Biliary tract cancer:

Cite this brief

Drug Landscape (2026). Biliary tract cancer — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/biliary-tract-cancer. Accessed 2026-06-10.

Biliary tract cancer full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing